Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chenxin Pharmaceutical, also known as Cisen Pharmaceutical, is a leading Chinese pharmaceutical company focused on the research, development, manufacturing, and sale of a wide range of chemical drug preparations. The company's extensive product portfolio includes large-volume injections, small-volume injections, tablets, capsules, and ointments covering therapeutic areas such as cardiovascular, anti-infective, digestive, and endocrine systems. Chenxin is particularly recognized for its strong manufacturing capabilities in intravenous infusions and its growing pipeline of innovative small molecules and complex generics. Headquartered in Jining, Shandong, the company is publicly traded on the Shanghai Stock Exchange and operates several R&D centers and manufacturing bases across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chenxin Pharmaceutical.